Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel first-line monotherapy in idiopathic generalized epilepsy
jRCTs031230053Completed
- Sponsor
- University of Tsukuba Hospital
- Start
- Nov 2023
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of perampanel in idiopathic epilepsy (IGE), sponsored by University of Tsukuba Hospital. Primary endpoint: Percentage seizure-free after 1 year of treatment intervention. Started Nov 2023; status: completed.
02
Drugs
perampanel
03
Conditions
idiopathic epilepsy (IGE)
Beyond the preview
Go deeper on jRCTs031230053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230053.